IC Patient Survey
ICA needs your feedback! This survey is supported by Aquinox Pharmaceuticals, Inc. De-identified responses will be shared with Aquinox, and reported in aggregate. ICA may also share the results (de-identified and in aggregate) with the FDA at an upcoming meeting to provide the voice of patients with IC/BPS to help shape future clinical trial designs and help the FDA understand what is important to patients.
Click here to take the survey.